000 01151 a2200313 4500
005 20250514025524.0
264 0 _c20020408
008 200204s 0 0 eng d
022 _a1472-8222
024 7 _a10.1517/14728222.6.1.21
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhasnobis, Shampa
245 0 0 _aEmerging therapeutic targets in tuberculosis: post-genomic era.
_h[electronic resource]
260 _bExpert opinion on therapeutic targets
_cFeb 2002
300 _a21-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aAntitubercular Agents
_xchemistry
650 0 4 _aCell Wall
_xchemistry
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aGenome, Bacterial
650 0 4 _aHumans
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aTuberculosis
_xdrug therapy
700 1 _aEscuyer, Vincent E
700 1 _aChatterjee, Delphi
773 0 _tExpert opinion on therapeutic targets
_gvol. 6
_gno. 1
_gp. 21-40
856 4 0 _uhttps://doi.org/10.1517/14728222.6.1.21
_zAvailable from publisher's website
999 _c11807426
_d11807426